Fast Money Episodes

Are Momentum Stocks Losing Steam?

[cnbc 3000084667] The Fast Money traders weigh in on whether Chipotle is a buy, sell or hold, and a look at how investors should trade overbought momentum stocks, with Barry Sine, Drexel Hamilton director of research. […]

Fast Money Episodes

Apple Nears Correction Territory

[cnbc 3000085277] Shares of Apple fall over 3 percent. A significant drop in Q1 Verizon activations and concerns Apple may miss its Q2 iPhone targets weighs heavily on the stock, which is down 9 percent since its April 10th high. […]

Max Keiser

Keiser Report: Vicious Circle of Bankster Huddles (ft. Matt Taibbi) (E277)

[youtube CBxBtK-2XJc] Follow Max Keiser on Twitter: http://twitter.com/maxkeiser In this episode, Max Keiser and co-host, Stacy Herbert discuss huddles and cuddles with the Goombahs of Wall Street and the technical violations that cannot be called by name. In the second half of the show Max talks to Rolling Stone journalist, Matt Taibbi, about the Wall Street mafia, their small and big time rackets and the process of writing these crime stories for a wide audience. […]

Fast Money Episodes

Spain Overshadowing Earnings?

[cnbc 3000085041] CNBC’s Michelle Caruso-Cabrera reports that the SEC expected to vote today on possible charges against Egan Jones. Willie Williams, Societe Generale, also discusses how today’s Spanish bond auction is impacting the global markets. […]

Fast Money Episodes

Inside Look at Qualcomm

[cnbc 3000085042] Shares of chipmaker Qualcomm are down 4% today after the company reported disappointing economic reports. Discussing whether there is still quality in the company, with Glen Yeung, Citi Investment Research managing director. […]

Fast Money Episodes

Buy Microsoft on Windows 8 Launch

[cnbc 3000085065] The FMHR traders discuss Wednesday’s impressive earnings data from VMware and F-5 Networks. Rob Breza, Enterprise software analyst, also explains why investors should buy Microsoft. […]

Fast Money Episodes

Are Mylan Analyst Cuts Just Coincidence?

[cnbc 3000085212] CNBC’s Herb Greenberg looks at why several analysts covering Mylan may have cut their first quarter earnings estimates within a few days of each other, citing concerns about the anti-depressant Lexapro. Herb’s question: ‘Did the company engage in some kind of selective disclosure?’ […]